Target intelligence / Profile preview

Solute carrier family 36 member 4 (SLC36A4)

Target
SLC36A4
Molecular classification
Transporter, Uniporter, Solute carrier family protein
01

Overview

Solute carrier family 36 member 4 (SLC36A4, also known as PAT4) is a high-affinity, low-capacity transporter of neutral amino acids, with strongest specificity for proline and tryptophan but lower affinity for alanine and glycine. Unlike other members of the SLC36 family, SLC36A4 operates independently of proton gradients (non-proton-coupled), through facilitated diffusion in an electroneutral and sodium-independent manner. Its function is maximal at physiological pH 7.4, and it is ubiquitously expressed in various tissues, including several cancer cell lines, where it may contribute to nutrient sensing via regulation of mTORC1 on the Golgi apparatus. SLC36A4 is structurally predicted to have 9–11 transmembrane domains and is encoded on human chromosome 11q21. Recent research suggests SLC36A4 may act more as a nutrient sensor (“transceptor”) rather than simply a bulk transporter for amino acids, with implications for growth regulation and cancer biology due to its role in the mTOR/S6 kinase signaling pathway. No specific drugs or inhibitors are currently approved to target SLC36A4, and its direct involvement in human disease remains under investigation.

Other names
Neutral amino acid uniporter 4PAT4Proton-coupled amino acid transporter 4Solute carrier family 36 member 4FLJ38932
02

Mechanism of action

Null (no drugs directly target this molecule as a mechanism of action)

03

Biological functions

Amino acid transportNutrient sensing (potential regulator of mTORC1 pathway)Regulation of cellular growth and metabolism
04

Disease associations

Cancer (high expression correlates with reduced relapse-free survival in colorectal cancer, possible implication in nutrient signaling in cancer cells)Iminoglycinuria (by pathway association rather than direct causation)Other (potential link with metabolic regulation and mTOR signaling)
05

Safety considerations

No notable safety concerns or therapeutic challenges are currently established for direct targeting
06

Interacting drugs

No drugs are currently known to directly target SLC36A4; inhibition and transport studies reference molecules such as proline, tryptophan, alanine, and sarcosine, but these are not considered therapeutic drugs for modulation of SLC36A4.

1 more in the full profile.

07

Biomarkers

High SLC36A4 expression (biomarker for reduced relapse-free survival in colorectal cancer)No established clinical biomarkers for efficacy monitoring or patient selection

Beyond the preview

Go deeper on Solute carrier family 36 member 4 (SLC36A4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 36 member 4 (SLC36A4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call